Children with type 1 diabetes have elevated high-sensitivity C-reactive protein compared with a control group

Area of Science:

• Pediatric Endocrinology
• Inflammation Biomarkers
• Metabolic Disorders

Background:

• Type 1 diabetes (T1D) management requires monitoring for complications.
• Inflammation, indicated by high-sensitivity C-reactive protein (hsCRP), is implicated in cardiovascular disease risk.
• Obesity is a growing concern in pediatric populations, often co-existing with chronic conditions.

Purpose of the Study:

• To compare hsCRP levels in children with T1D, healthy controls, and children with obesity.
• To investigate the association between hsCRP and glycemic control (HbA1c), anthropometric, and biochemical variables in these groups.

Main Methods:

• A non-randomized descriptive study involving 49 children with T1D, 46 controls, and 40 children with obesity.
• hsCRP levels were measured using ELISA.
• Data collected included anthropometric parameters, blood pressure, lipid profile, HbA1c, and albumin to creatinine ratio.

Main Results:

• Children with T1D showed significantly higher hsCRP levels than controls.
• hsCRP levels were nearly significantly lower in T1D compared to children with obesity.
• hsCRP correlated significantly with body mass index (BMI) and waist circumference Z-score, but not with HbA1c.

Conclusions:

• Elevated hsCRP in T1D children, even with similar BMI to controls, suggests a basal inflammatory state.
• This inflammation may increase cardiovascular risk in pediatric T1D.
• Obesity prevention and management are crucial in the follow-up of children with T1D due to the strong link between hsCRP, BMI, and waist circumference.